<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01818154</url>
  </required_header>
  <id_info>
    <org_study_id>7257</org_study_id>
    <nct_id>NCT01818154</nct_id>
  </id_info>
  <brief_title>Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)</brief_title>
  <official_title>Validation of a New Hand Held Light Emitting Diode (LED) Device for the Determination of Minimal Erythema Dose (MED) for Narrowband Ultraviolet B.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henry Ford Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henry Ford Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to validate a new hand held light emitting diode (LED) device
      for the measurement of minimal erythema dose (MED) for narrow band Ultraviolet B (UVB)
      radiation by comparing to the traditional approach of measurement of the minimal erythema
      dose.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Under evaluation for need for further enrollment
  </why_stopped>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Minimal Erythema Dose</measure>
    <time_frame>1 day</time_frame>
    <description>The Investigator will look at area irradiated and evaluate for erythema. The lowest dose at which erythema is noted will be recorded as the minimal erythema dose.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Phototherapy</condition>
  <arm_group>
    <arm_group_label>Minimal Erythema Dose LED</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 2 x 2 cm section of skin will be exposed to LED light.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Minimal Erythema Dose narrow band UVB</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A 2 x 2 cm section of skin will be exposed to narrow band UVB light.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>LED phototherapy</intervention_name>
    <arm_group_label>Minimal Erythema Dose LED</arm_group_label>
    <arm_group_label>Minimal Erythema Dose narrow band UVB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>narrowband UVB phototherapy</intervention_name>
    <arm_group_label>Minimal Erythema Dose LED</arm_group_label>
    <arm_group_label>Minimal Erythema Dose narrow band UVB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Age greater than 18 years.

        Exclusion Criteria:

          1. Pregnancy

          2. Lactation

          3. History of photosensitivity disorder

          4. Photosensitizing medications

          5. Personal history of melanoma or non-melanoma skin cancer.

          6. Skin disease on the back
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iltefat H Hamzavi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henry Ford Dermatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Henry Ford Medical Center Department of Dermatology</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2013</study_first_submitted>
  <study_first_submitted_qc>March 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2013</study_first_posted>
  <last_update_submitted>March 25, 2013</last_update_submitted>
  <last_update_submitted_qc>March 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henry Ford Health System</investigator_affiliation>
    <investigator_full_name>Iltefat Hamzavi</investigator_full_name>
    <investigator_title>Senior Staff Physician</investigator_title>
  </responsible_party>
  <keyword>phototherapy</keyword>
  <keyword>light emitting diode</keyword>
  <keyword>minimal erythema dose</keyword>
  <keyword>narrowband UVB</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erythema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

